MedPath

GABAPENTIN CAPSULES

GABAPENTIN CAPSULES

Discontinued
DIN Number

02332582

Drug Class

Human

Market Date

N/A

Company
HC

ranbaxy pharmaceuticals canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02332582
AIG Number0125929001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GABAPENTINActive
Strength: 100 MG
Monograph: GABAPENTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.